Assignee
CEPHALON LLC
US·9 granted patents·12 pending applications·2 citations·filing 2021–2025
Top patents by PatentIndex Score
21 records- 0189US11725052B2Anti-PAR-2 antibodies and methods of use thereofCEPHALON LLC·Filed 2021·Granted Aug 15, 2023·2 cites·26 claims
- 0287US2025257035A11,4-Substituted Piperidine DerivativesCEPHALON LLC·Filed 2024·Application pending·0 cites
- 0384US2025179202A1Antibodies That Specifically Bind to TL1A and Methods of Treating Skin DiseaseCEPHALON LLC·Filed 2024·Application pending·0 cites
- 0480US12441702B2Substituted 4-benzyl and 4-benzoyl piperidine derivatesCEPHALON LLC·Filed 2023·Granted Oct 14, 2025·0 cites·6 claims
- 0578US2024301076A1Anti-cxcr2 antibodies and uses thereofCEPHALON LLC·Filed 2024·Application pending·0 cites
- 0677US12384841B2Anti-PAR-2 antibodies and methods of use thereofCEPHALON LLC·Filed 2023·Granted Aug 12, 2025·0 cites·3 claims
- 0777US12162946B2Antibodies that specifically bind to TL1A and methods of treating gastrointestinal diseaseCEPHALON LLC·Filed 2021·Granted Dec 10, 2024·0 cites·31 claims
- 0876US2026062478A1Anti-par-2 antibodies and methods of use thereofCEPHALON LLC·Filed 2025·Application pending·0 cites
- 0973US12018084B2Anti-CXCR2 antibodies and uses thereofCEPHALON LLC·Filed 2022·Granted Jun 25, 2024·0 cites·25 claims
- 1072US12281148B2Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereofCEPHALON LLC·Filed 2024·Granted Apr 22, 2025·0 cites·10 claims
- 1171US12410247B2Polynucleotides encoding antibodies that specifically bind to human IL-15CEPHALON LLC·Filed 2022·Granted Sep 9, 2025·0 cites·20 claims
- 1264US12577298B2Anti-IL-5 antibodiesCEPHALON LLC·Filed 2021·Granted Mar 17, 2026·0 cites·12 claims
- 1364US2026083857A1Anti-pd-1 antibody-attenuated il-2 immunoconjugate formulationsCEPHALON LLC·Filed 2025·Application pending·0 cites
- 1463US2024076343A1Anti-pd-1 antibody-attenuated il-2 immunoconjugates and uses thereofCEPHALON LLC·Filed 2023·Application pending·0 cites
- 1562US2023060770A1Cation exchange chromatography wash bufferCEPHALON LLC·Filed 2022·Application pending·0 cites
- 1661US12358980B2Compositions and methods for anti-PACAP antibodiesCEPHALON LLC·Filed 2022·Granted Jul 15, 2025·0 cites·20 claims
- 1761US2025195677A1Uses for attenuated il-2 immunoconjugatesCEPHALON LLC·Filed 2024·Application pending·0 cites
- 1860US2025122291A1Anti-trka antibodies and uses thereofCEPHALON LLC·Filed 2024·Application pending·0 cites
- 1955US2024150447A1Compositions and methods for increasing transport into the brainCEPHALON LLC·Filed 2023·Application pending·0 cites
- 2048US2025263494A1Anti-tl1a antibody formulationsCEPHALON LLC·Filed 2025·Application pending·0 cites
- 2140US2025270336A1Anti-tl1a antibodies for the treatment of ulcerative colitis and crohn's diseaseCEPHALON LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CEPHALON LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →